160 related articles for article (PubMed ID: 32698792)
21. Effects of Iron Chelation in Osteosarcoma.
Argenziano M; Di Paola A; Tortora C; Di Pinto D; Pota E; Di Martino M; Perrotta S; Rossi F; Punzo F
Curr Cancer Drug Targets; 2021; 21(5):443-455. PubMed ID: 33380300
[TBL] [Abstract][Full Text] [Related]
22. Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells.
Legendre C; Avril S; Guillet C; Garcion E
BMC Cancer; 2016 Feb; 16():51. PubMed ID: 26832741
[TBL] [Abstract][Full Text] [Related]
23. Destructive effect of iron overload in brain tissue of albino rats: Ameliorative role of silver immobilized organo-modified casein nanocomposite as co-treating agent with Deferasirox.
Adel RM; Lotfy RA; Darwish AS; Amer AS
J Trace Elem Med Biol; 2021 Sep; 67():126794. PubMed ID: 34052583
[TBL] [Abstract][Full Text] [Related]
24. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases.
Taniuchi K; Nakagawa H; Hosokawa M; Nakamura T; Eguchi H; Ohigashi H; Ishikawa O; Katagiri T; Nakamura Y
Cancer Res; 2005 Apr; 65(8):3092-9. PubMed ID: 15833838
[TBL] [Abstract][Full Text] [Related]
25. Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma.
Saeki I; Yamamoto N; Yamasaki T; Takami T; Maeda M; Fujisawa K; Iwamoto T; Matsumoto T; Hidaka I; Ishikawa T; Uchida K; Tani K; Sakaida I
World J Gastroenterol; 2016 Oct; 22(40):8967-8977. PubMed ID: 27833388
[TBL] [Abstract][Full Text] [Related]
26. Interference of deferasirox with assays for serum iron and serum unsaturated iron binding capacity during iron chelating therapy.
Ikuta K; Ito S; Tanaka H; Sasaki K; Torimoto Y; Fujiya M; Kohgo Y
Clin Chim Acta; 2011 Nov; 412(23-24):2261-6. PubMed ID: 21884685
[TBL] [Abstract][Full Text] [Related]
27. Deferasirox combination with eltrombopag shows anti-myelodysplastic syndrome effects by enhancing iron deprivation-related apoptosis.
Huang L; Tian M; Liu Z; Liu C; Fu R
J Investig Med; 2022 Apr; 70(4):953-962. PubMed ID: 34921125
[TBL] [Abstract][Full Text] [Related]
28. Iron Chelator Deferasirox Reduces
Puri S; Kumar R; Rojas IG; Salvatori O; Edgerton M
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718249
[No Abstract] [Full Text] [Related]
29. Saponins extracted from by-product of Asparagus officinalis L. suppress tumour cell migration and invasion through targeting Rho GTPase signalling pathway.
Wang J; Liu Y; Zhao J; Zhang W; Pang X
J Sci Food Agric; 2013 Apr; 93(6):1492-8. PubMed ID: 23450726
[TBL] [Abstract][Full Text] [Related]
30. Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets.
Cheng WY; Said Q; Hao Y; Xiao Y; Vekeman F; Bobbili P; Duh MS; Nandal S; Blinder M
Curr Med Res Opin; 2018 Nov; 34(11):1959-1966. PubMed ID: 29701080
[TBL] [Abstract][Full Text] [Related]
31. The iron chelator Deferasirox causes severe mitochondrial swelling without depolarization due to a specific effect on inner membrane permeability.
Gottwald EM; Schuh CD; Drücker P; Haenni D; Pearson A; Ghazi S; Bugarski M; Polesel M; Duss M; Landau EM; Kaech A; Ziegler U; Lundby AKM; Lundby C; Dittrich PS; Hall AM
Sci Rep; 2020 Jan; 10(1):1577. PubMed ID: 32005861
[TBL] [Abstract][Full Text] [Related]
32. Cdc42 Mediates Cancer Cell Chemotaxis in Perineural Invasion.
Chernichenko N; Omelchenko T; Deborde S; Bakst RL; He S; Chen CH; Gusain L; Vakiani E; Katabi N; Hall A; Wong RJ
Mol Cancer Res; 2020 Jun; 18(6):913-925. PubMed ID: 32086369
[TBL] [Abstract][Full Text] [Related]
33. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.
Jiménez-Solas T; López-Cadenas F; Aires-Mejía I; Caballero-Berrocal JC; Ortega R; Redondo AM; Sánchez-Guijo F; Muntión S; García-Martín L; Albarrán B; Alonso JM; Del Cañizo C; Hernández-Hernández Á; Díez-Campelo M
Br J Haematol; 2019 Oct; 187(1):93-104. PubMed ID: 31172513
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload.
Wu D; Wen X; Liu W; Hu H; Ye B; Zhou Y
Drug Des Devel Ther; 2018; 12():1081-1091. PubMed ID: 29760547
[TBL] [Abstract][Full Text] [Related]
35. Cooperative anti-invasive effect of Cdc42/Rac1 activation and ROCK inhibition in SW620 colorectal cancer cells with elevated blebbing activity.
de Toledo M; Anguille C; Roger L; Roux P; Gadea G
PLoS One; 2012; 7(11):e48344. PubMed ID: 23144867
[TBL] [Abstract][Full Text] [Related]
36. Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562.
Li N; Chen Q; Gu J; Li S; Zhao G; Wang W; Wang Z; Wang X
Oncotarget; 2017 May; 8(22):36517-36530. PubMed ID: 28388554
[TBL] [Abstract][Full Text] [Related]
37. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
38. Carbon-Ion Irradiation Suppresses Migration and Invasiveness of Human Pancreatic Carcinoma Cells MIAPaCa-2 via Rac1 and RhoA Degradation.
Fujita M; Imadome K; Shoji Y; Isozaki T; Endo S; Yamada S; Imai T
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):173-80. PubMed ID: 26279033
[TBL] [Abstract][Full Text] [Related]
39. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
[TBL] [Abstract][Full Text] [Related]
40. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
